The Cooper Companies, Inc. $COO Shares Purchased by Coldstream Capital Management Inc.

Coldstream Capital Management Inc. lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 249.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,810 shares of the medical device company’s stock after acquiring an additional 4,860 shares during the period. Coldstream Capital Management Inc.’s holdings in Cooper Companies were worth $485,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in COO. Horizon Investments LLC increased its holdings in Cooper Companies by 5.0% in the 1st quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company’s stock valued at $241,000 after purchasing an additional 136 shares in the last quarter. Wealth Alliance LLC boosted its position in shares of Cooper Companies by 4.2% in the second quarter. Wealth Alliance LLC now owns 4,230 shares of the medical device company’s stock worth $301,000 after buying an additional 171 shares during the period. State of Michigan Retirement System boosted its position in shares of Cooper Companies by 0.4% in the second quarter. State of Michigan Retirement System now owns 54,344 shares of the medical device company’s stock worth $3,867,000 after buying an additional 200 shares during the period. New York Life Investment Management LLC grew its stake in shares of Cooper Companies by 0.7% in the second quarter. New York Life Investment Management LLC now owns 30,019 shares of the medical device company’s stock valued at $2,136,000 after buying an additional 210 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its holdings in shares of Cooper Companies by 3.5% during the 1st quarter. EverSource Wealth Advisors LLC now owns 6,517 shares of the medical device company’s stock valued at $550,000 after buying an additional 220 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Down 0.3%

NASDAQ:COO opened at $77.94 on Friday. The company has a market capitalization of $15.50 billion, a price-to-earnings ratio of 38.39, a price-to-earnings-growth ratio of 1.83 and a beta of 1.02. The Cooper Companies, Inc. has a one year low of $61.78 and a one year high of $106.63. The stock has a 50-day simple moving average of $71.11 and a 200 day simple moving average of $71.93. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The firm had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.06 billion. During the same quarter in the prior year, the firm posted $0.96 earnings per share. Cooper Companies’s revenue for the quarter was up 5.7% compared to the same quarter last year. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies declared that its board has approved a stock buyback plan on Wednesday, September 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the medical device company to repurchase up to 15.4% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board believes its stock is undervalued.

Insiders Place Their Bets

In other news, Director Lawrence Erik Kurzius purchased 2,000 shares of the company’s stock in a transaction that occurred on Monday, September 29th. The shares were acquired at an average cost of $68.39 per share, with a total value of $136,780.00. Following the transaction, the director owned 5,777 shares in the company, valued at approximately $395,089.03. The trade was a 52.95% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Daniel G. Mcbride acquired 3,000 shares of Cooper Companies stock in a transaction that occurred on Tuesday, September 2nd. The shares were purchased at an average price of $65.04 per share, for a total transaction of $195,120.00. Following the completion of the purchase, the chief operating officer directly owned 63,120 shares of the company’s stock, valued at $4,105,324.80. The trade was a 4.99% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders purchased 17,975 shares of company stock worth $1,216,346. Corporate insiders own 1.98% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Barclays assumed coverage on Cooper Companies in a report on Monday, October 13th. They issued an “overweight” rating and a $85.00 price target for the company. Weiss Ratings upgraded shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday. Morgan Stanley set a $76.00 price target on shares of Cooper Companies and gave the stock an “equal weight” rating in a research note on Thursday, August 28th. The Goldman Sachs Group set a $64.00 price objective on shares of Cooper Companies and gave the company a “sell” rating in a research report on Wednesday, October 1st. Finally, Wells Fargo & Company reaffirmed an “equal weight” rating and set a $72.00 target price on shares of Cooper Companies in a research report on Thursday, November 13th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $84.77.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.